Antivirals for treatment of HIV infections, combinations
Lamivudine/Nevirapine/Zidovudine Tablets
Composition
- Active ingredients
- Lamivudine 30MG; Nevirapine 50MG; Zidovudine 60MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA200793.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lamivudine/Nevirapine/Zidovudine Tablets
- Active substance
- Lamivudine
- Drug class
- Antivirals for treatment of HIV infections, combinations
- Group
- Antivirals
- Route
- Oral
- Dosage form
- Tablet, for suspension
- Applicant
- Matrix Labs
- Status
- Tentative approval